Ma Yingli has filed 11 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 32526 shares of Structure Therapeutics Inc. ($GPCR) on March 19, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | Structure Therapeutics Inc. | $GPCR | Ma Yingli | CHIEF TECHNOLOGY OFFICER | A | Ordinary Shares | 32526 | $0.00 | 139,917.0000 | 177,596,000 | 30.29% | 0.02% |
| March 19, 2026 | Structure Therapeutics Inc. | $GPCR | Ma Yingli | CHIEF TECHNOLOGY OFFICER | A | Employee Stock Option (right to buy) | 40278 | $0.00 | 40,278.0000 | 177,596,000 | 9999.99% | 0.02% |
| March 3, 2026 | Structure Therapeutics Inc. | $GPCR | Ma Yingli | CHIEF TECHNOLOGY OFFICER | F | Ordinary Shares | 11313 | $20.99 | 107,391.0000 | 177,596,000 | 9.53% | 0.01% |
| July 1, 2025 | Structure Therapeutics Inc. | $GPCR | Ma Yingli | CHIEF TECHNOLOGY OFFICER | F | Ordinary Shares | 4470 | $6.84 | 118,704.0000 | 172,351,000 | 3.63% | 0.00% |
| July 1, 2025 | Structure Therapeutics Inc. | $GPCR | Ma Yingli | CHIEF TECHNOLOGY OFFICER | A | Ordinary Shares | 24459 | $0.00 | 123,174.0000 | 172,351,000 | 24.78% | 0.01% |
| March 1, 2025 | Structure Therapeutics Inc. | $GPCR | Ma Yingli | CHIEF TECHNOLOGY OFFICER | F | Ordinary Shares | 1824 | $7.92 | 98,715.0000 | 157,922,000 | 1.81% | 0.00% |
| March 15, 2025 | Structure Therapeutics Inc. | $GPCR | Ma Yingli | CHIEF TECHNOLOGY OFFICER | A | Ordinary Shares | 63810 | $0.00 | 100,539.0000 | 157,922,000 | 173.73% | 0.04% |
| March 15, 2025 | Structure Therapeutics Inc. | $GPCR | Ma Yingli | CHIEF TECHNOLOGY OFFICER | A | Employee Stock Option (right to buy) | 155040 | $0.00 | 155,040.0000 | 157,922,000 | 9999.99% | 0.10% |
| March 15, 2024 | Structure Therapeutics Inc. | $GPCR | Ma Yingli | CHIEF TECHNOLOGY OFFICER | A | Stock Option (right to buy) | 91494 | $0.00 | 91,494.0000 | 110,198,000 | 9999.99% | 0.08% |
| March 15, 2024 | Structure Therapeutics Inc. | $GPCR | Ma Yingli | CHIEF TECHNOLOGY OFFICER | A | Ordinary Shares | 36729 | $0.00 | 36,729.0000 | 110,198,000 | 9999.99% | 0.03% |
| March 15, 2024 | Structure Therapeutics Inc. | $GPCR | Ma Yingli | CHIEF TECHNOLOGY OFFICER | A | Stock Option (right to buy) | 91494 | $0.00 | 91,494.0000 | 110,198,000 | 9999.99% | 0.08% |